![Sample our Food Science & Technology journals, sign in here to start your access, latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/5936/TOC-Subject-Sample-2021-Food-Science-Technology.jpg"})
Abstract
Glycemic Index (GI) is a measure of carbohydrate quality and is recognised as a valid and reproducible method of classifying carbohydrate foods according to its effects on postprandial glycaemia. In this randomised crossover trial (RBR-7rjx3k) we determined the GI of nine enteral formulas, following the Food and Agriculture Organisation/World Health Organisation method. Forty healthy participants were included in the study (85% female mean age 27.1 ± 6.7 years). GI of the enteral formulas ranged from 40.5 to 85.2; four formulas had high GI (Nutrienteral 1.5®, Novasource GI Control®, Diamax®, Isosource Soya®), two intermediate GI (Fresubin 1.2 HP Fibre®, Nutrison Energy Multifiber 1.5®) and three low GI (Trophic 1.5®, Glucerna®, Novasource GC HP®). The GI coefficient of variation ranged from 22.9% to 83.6%. The effect of the enteral formulas with low GI in glycemic control of patients with enteral nutrition prescription needs to be test in future studies.
Acknowledgments
The authors thank the volunteers for their participation in the study and the Risoleta Tolentino Neves Hospital for the donation of some of the enteral formulas analysed.
Disclosure statement
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Notes on contributors
F.M.S contributed to the study design, coordination of all phases of the study and conception of this manuscript. J.A.G.T collected the data, conducted the statistical analyses and interpretation of results; and drafted the manuscript. V.B. recruited the volunteers and contributed to data collection. A.K.J and H.B. were responsible for the acquisition of the enteral formulas and contributed to the study design. All authors revised and approved the final version of this paper.